Mutant TDP-43 deregulates AMPK activation by PP2A in ALS models.
Bioenergetic abnormalities and metabolic dysfunctionoccur in amyotrophic lateral sclerosis (ALS) patients and genetic mouse models. However, whether metabolic dysfunction occurs earlyin ALS pathophysiology linked to different ALS genes remains unclear.Here, we investigatedAMP-activated protein kinas...
Saved in:
| Main Authors: | Nirma D Perera, Rebecca K Sheean, John W Scott, Bruce E Kemp, Malcolm K Horne, Bradley J Turner |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0090449&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Coding and non-coding RNA expression in NSC34 cells following TDP-43 depletion and mutant TDP-43 M337V expression
by: Ismail Gbadamosi, et al.
Published: (2025-07-01) -
Progranulin is neurotrophic in vivo and protects against a mutant TDP-43 induced axonopathy.
by: Angela S Laird, et al.
Published: (2010-10-01) -
Optineurin knock-out forms TDP-43 aggregates to regulate TDP-43 protein levels despite autophagic up-regulation and aberrant TDP-43 expression
by: Yuta Maetani, et al.
Published: (2025-07-01) -
Molecular mechanisms and consequences of TDP-43 phosphorylation in neurodegeneration
by: Elise A. Kellett, et al.
Published: (2025-05-01) -
Extracellular vesicles in TDP-43 proteinopathies: pathogenesis and biomarker potential
by: Elizabeth R. Dellar, et al.
Published: (2025-06-01)